Eli Lilly and Co（LLY）股票分析LLYEli Lilly and Co

Rotation into defensive sectors like healthcare this morning. Here's $LLY, which continues to set up constructively.

$NVO $LLY Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro - Reuters

VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 'Multi-Blockbusters' $VKTX $NVO $LLY $GPCR $ALT

$SPY $DKNG $LLY $PSKY $VLVLY 1) In a post on Truth Social, President Trump states: "...I will be announcing, in the near future, the AI 'Czar' - Only High I.Q. individuals need apply! AI is the next Industrial Revolution, or Internet, but will be even larger and more impactful, possibly as much as 25% of our Country's GDP. We are leading China, and the rest of the World, and I intend to keep it that way!" 2) DraftKings (DKNG) puts customer betting records into a machine learning model to find out who is most likely to make losing bets, Alex Klavens, Walt Bogdanich and Jenny Vrentas of New York Times report. The company uses data science to target losing gamblers with promotions that encourage more betting, six former employees told the Times. 3) Some emerging scientific research points to an increased risk for GLP-1 patients to develop nonarteritic anterior ischemic optic neuropathy, or vision loss, Alex Janin of Wall Street Journal reports. GLP-1 developers Novo Nordisk (NVO) and Eli Lilly (LLY) face lawsuits from patients claiming the medications caused NAION, the Journal adds. 4) Paramount (PSKY) and states looking to block its acquisition of Warner Bros. (WBD) could settle as soon as this week, Jody Godoy of Reuters reports, citing sources familiar with the matter. A commitment on the number of movie releases is among the terms of the settlement, the sources added. 5) The Board of Directors of Volvo Cars (VLVLY) has appointed Klaus Zellmer as President and Chief Executive Officer. Klaus Zellmer will assume the position no later than 1 October 2027. Hakan Samuelsson will, together with the Board, ensure a seamless transition. Klaus Zellmer most recently served Chairman of the Board of Management and CEO of Skoda Auto, a Volkswagen (VWAGY) company.

$LLY $NVO Lilly and Novo face lawsuits over GLP-1 vision loss risk, WSJ says. Some emerging scientific research points to an increased risk for GLP-1 patients of developing nonarteritic anterior ischemic optic neuropathy, or vision loss, Alex Janin of the Wall Street Journal reports. GLP-1 developers Novo Nordisk (NVO) and Eli Lilly (LLY) face lawsuits from patients claiming the medications caused NAION, the Journal adds. Evidence of the vision loss risk is mixed and not clear enough to say whether or how the drugs cause the condition, doctors and researchers said, according to the Journal.